Edition:
India

BBI Life Sciences Corp (1035.HK)

1035.HK on Hong Kong Stock

2.70HKD
15 Nov 2018
Change (% chg)

-- (--)
Prev Close
HK$2.70
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
174,106
52-wk High
HK$4.42
52-wk Low
HK$2.20

Summary

Name Age Since Current Position

Qisong Wang

73 2014 Chairman of the Board, Executive Director

Jin Wang

2014 President, Executive Director

Luojia Wang

45 2014 Chief Executive Officer, Executive Director

Xiaolei Gu

38 2015 Chief Financial Officer

Xuyu Hu

2014 Vice President

Qingfeng Jiao

46 2014 Vice President

Ruifeng Li

38 2014 Vice President

Wei Li

31 2014 Vice President

Hua Yan

48 2014 Vice President

Mi Zhou

35 2018 Non-Executive Director

Kai Chung Ho

2014 Independent Non-executive Director

Jianjun Liu

46 2014 Independent Non-executive Director

Lijun Xia

38 2014 Independent Non-executive Director

Biographies

Name Description

Qisong Wang

Wang Qisong is Chairman of the Board, Executive Director of Bbi Life Sciences Corporation. He is the founder of our Group. He was appointed as a Director and the chairman of the Board of our Company on 16 January 2014 and became our executive Director on 10 October 2014, and is primarily responsible for our Group’s development, positioning and strategy planning. He was one of the founders of Shanghai Sangon Biological Engineering Technology & Services Co, Ltd. (“SSBETS”) in 2001, was a director of BBI US from 2009 to 2010 and is currently chairman and director of Sangon Biotech and an executive director of BBI China. Mr. Wang has nearly 50 years of experience in the biotechnology industry. Prior to joining our Group, from August 1965 to May 1985 he worked as an assistant researcher in the Institute of Biochemistry and Cell Biology, Shanghai Institutes for Biological Sciences, China Academy of Sciences and from March 1980 to March 1983, Mr. Wang Qisong was seconded to the University of Toronto in Canada as a visiting scholar. From June 1985 to October 1991, he was an associate professor in the Institute of Genetics, School of Life Sciences, Fudan University. From June 1987 to December 1989, he was an expert member in the Biotechnology Group of the State High-Tech Development Plan (863 Programme). From March 1991 to August 1991, he was a consultant in the United Nations Industrial Development Organization. He is currently a supervisor of Wuhan Wenwang Cultural Education and Communication Limited. Mr. Wang graduated from Wuhan University in Hubei Province, PRC with a Bachelor of Science in Organic Chemistry in July 1965.

Jin Wang

Ms. Wang Jin is President, Executive Director of Bbi Life Sciences Corporation. She was appointed as an executive Director and the president of our Company on 26 September 2014 and 16 January 2014 respectively and is primarily responsible for our Group’s strategies and operational management, overseas sales and development, and overall operations of Bio Basic (Canada) and Bio Basic (US). Ms. Wang is currently a director of Bio Basic (Canada), Bio Basic (US), Sangon Biotech, BBI Asia and BBI International. Ms. Wang graduated from the University of Calgary in Alberta, Canada with a Master of Science degree in Biochemistry and Molecular Biology in November 1997. She was a director of BBI Canada from 2005 to 2011 and BBI US from 2009 to 2012. Since June 2012, she was a senior deputy general manager of Sangon Biotech, and was the president of Bio Basic (Canada) and Bio Basic (US) since November 2010 and December 2010 respectively.

Luojia Wang

Ms. Luojia Wang is Chief Executive Officer, Executive Director of Bbi Life Sciences Corporation. She was appointed as an executive Director and the chief executive officer of our Company on 26 September 2014 and 16 January 2014 respectively and is primarily responsible for our Group’s strategies and overall operation management. Ms. Wang is currently a director of Bio Basic (Canada), Sangon Biotech, BBI Asia and BBI International. Ms. Wang graduated from the University of Calgary in Alberta, Canada with a Bachelor of Science in Chemistry in June 1995. In April 2006, she returned to China and worked as a general manager at SSBETS. Subsequently, she became general manager of Sangon Biotech in October 2009.

Xiaolei Gu

Mr. Gu Xiaolei is Chief Financial Officer of the Company. He has joined the Company since February 2015 and was appointed as Vice Financial Controller of the Company. Mr. Gu has over 15 years of financial management experience in bio-medical industry of the People’s Republic of China. Mr. Gu holds a Bachelor degree in Economics from Shanghai University of Finance and Economics.

Xuyu Hu

Mr. Hu Xuyu is Vice President of Bbi Life Sciences Corporation. He was appointed as a vice president of our Company on 16 January 2014. He joined Sangon Biotech as a deputy general manager in October 2010. From November 2007 to June 2010, he worked as a Regional Manager at Primary Care BU Department of Sanofi (China) Investment Co., Ltd.. Subsequently from June 2010 to October 2010, he was the vice president of investment at HaiTong KaiYuan Investment Co. Ltd. Mr. Hu obtained his Bachelor of Engineering in Pharmaceutical Production from Zhejiang University of Technology in the PRC in July 2000. He obtained the Master of Medical Science in Pharmacology from Soochow University in the PRC in June 2005. He subsequently obtained his Master of Business Administration after completing the EMBA Programme at China Europe International Business School in September 2012.

Qingfeng Jiao

Mr. Jiao Qingfeng is Vice President of Bbi Life Sciences Corporation. He was appointed as a vice president of our Company on 16 January 2014. He joined our Group in June 2010 as sales director and since June 2012 has been a Deputy General Manager of Sangon Biotech. From November 2006 to May 2008 he was a national sales manager at Abbott Laboratories Trading (Shanghai) Co., Ltd. From December 2008 to December 2009, he was a market development manager and from January 2010 to June 2010 he was a distribution manager at QIAGEN China (Shanghai) Co., Ltd. Mr. Jiao obtained his Master of Business Administration from Nanjing University in Nanjing in July 2000. Mr. Jiao has not held any directorship in any other public companies the securities of which are or have been listed on any securities market in Hong Kong or overseas in the past three years.

Ruifeng Li

Mr. Li Ruifeng is Vice President of Bbi Life Sciences Corporation. He was appointed as a vice president of our Company on 16 January 2014. Mr. Li joined SSBETS in 2001 and has been a director and deputy general manager of Sangon Biotech since May 2008 and October 2009 respectively. He finished his undergraduate course in microbiology at Inner Mongolia University in the PRC in July 2001. Mr. Li has not held any directorship in any other public companies the securities of which are or have been listed on any securities market in Hong Kong or overseas in the past three years.

Wei Li

Mr. Li Wei is Vice President of Vice President of Bbi Life Sciences Corporation. He was appointed as a vice president of our Company on 16 January 2014. He joined SSBETS and Sangon Biotech in August 2009 and October 2009 respectively, and since May 2010 has been a Deputy General Manager of Sangon Biotech. Mr. Li was a research assistant at the Plant Biotechnology Research Centre of Shanghai Jiao Tong University* from September 2008 to August 2009. Mr. Li obtained his Doctor of Philosophy in Genetics from Fudan University in Shanghai in January 2012. Mr. Li has not held any directorship in any other public companies the securities of which are or have been listed on any securities market in Hong Kong or overseas in the past three years.

Hua Yan

Mr. Yan Hua is Vice President of Bbi Life Sciences Corporation. He was appointed as a vice president of our Company on 16 January 2014. He joined our Group in June 2011 as technical director and since June 2012 has been a Deputy General Manager of Sangon Biotech. From February 2008 to May 2011, Mr. Yan was a Deputy General Manager of Neweast (Wuhan) Biosciences Limited. Mr. Yan obtained his Doctor of Philosophy in Immunology from Wuhan Institute of Biological Products in Hubei Province, PRC in 2012. Mr. Yan has not held any directorship in any other public companies the securities of which are or have been listed on any securities market in Hong Kong or overseas in the past three years.

Mi Zhou

Mr. Zhou Mi is Non-Executive Director of the Company. He has joined Bio Basic Inc. since July 2007, and was appointed as a department director of the Company on 16 January 2014. In his role, he is responsible for the manufacture and sale in overseas market. Mr. Zhou graduated and obtained Bachelor of Science in Biochemistry from Carleton University in Ottawa, Canada in 2007.

Kai Chung Ho

Mr. HO Kenneth Kai Chung is Independent Non-executive Director of Bbi Life Sciences Corporation. He was appointed as an Independent Non-executive Director of our Company on 10 October 2014. Mr. Ho has served successively as head of China research, China strategist and equity sales in top international investment banks. They include Credit Lyonnais, Jardine Fleming, JP Morgan and HSBC from 1999 to 2013. From 2008 to 2010, he set up Beijing research office for HSBC, established and acted as leader of the local research team as well as the chief representative for the research office. From 2011 till January 2013, Mr. Ho worked as a Hong Kong China equity sales director for HSBC. Mr. Ho obtained his Bachelor of Economics from The University of Sydney in May 1988 and Master of Commence in Finance from The University of New South Wales in April 1991. Mr. Ho was awarded a Chartered Financial Analyst in January 1999. Mr. Ho has been an independent non-executive director of TK Group (Holdings) Limited (stock code: 02283) a company listed on the Stock Exchange, since 27 November 2013. Mr. Ho had been an independent non-executive director of TLT Lottotainment Group Limited (stock code: 8022), a company listed on the Growth Enterprise Market of the Stock Exchange, since 22 November 2013 to 1 April 2014.

Jianjun Liu

Mr. Liu Jianjun is Independent Non-executive Director of Bbi Life Sciences Corporation. He was appointed as an Independent Non-executive Director on 10 October 2014. Mr. LIU was in the legal department of China Ocean Shipping (Group) Company container lines from July 1993 to March 1999, a partner at Zhong Sheng Law Firm, Beijing from April 2001 to October 2006, a senior associate in Zhong Lun Law Firm, Beijing from November 2006 to May 2007, and has been a partner at Zhonglun W&D Law Firm, Beijing from June 2007 to around 2012. Mr. Liu started practicing as a lawyer in the PRC in August 2001. Mr. Liu obtained a master’s degree in law from Peking University, the PRC, in July 1998, and a law degree from Washington University in St. Louis, the U.S., in May 2004. Mr. Liu has been an independent non-executive director of Nexteer Automotive Group Limited (stock code: 01316), a company listed on the Hong Kong Stock Exchange, since 15 June 2013.

Lijun Xia

Mr. Xia Lijun is Independent Non-executive Director of Bbi Life Sciences Corporation. He was appointed as an Independent Non-executive Director of our Company on 16 January 2014. Mr. Xia was an independent director of Sangon Biotech from 2012 to 2013. From June 2008 to March 2011, he was a professor in the School of Accountancy in the Shanghai University of Finance and Economics in the PRC. Since March 2011, he has been a professor and head of department in the Department of Accounting, Antai College of Economics and Management, Shanghai Jiao Tong University in the PRC. Mr. Xia obtained his Doctor of Philosophy in Management (Accounting) from the Shanghai University of Finance and Economics in the PRC in March 2006. Mr. Xia has been an independent director of Shanghai Guangdian Electric Group Co. Ltd. (stock code: 601616), a company listed on the Shanghai Stock Exchange, since April 2014.